Opinion

Video

The Diagnosis of Atopic Dermatitis

Expert advanced practice providers in dermatology discuss the diagnosis of atopic dermatitis.

This is a video synopsis/summary of a panel discussion involving Melodie Young, NP, and Andrea Nguyen, PA.

At the outset, Melodie Young, NP, emphasizes the clinical nature of atopic dermatitis (AD), highlighting the Hanifin and Rajka diagnostic criteria. To confirm a diagnosis, at least 3 main features—pruritus, typical morphology, and distribution—are required, with additional considerations such as chronic relapsing dermatitis and a history of atopy.

Andrea Nguyen, PA, discusses the diverse presentation of AD, emphasizing variations between adult and pediatric patients. The diagnostic criteria include major features like flexor lichenification and extensor eruptions in adults, and facial and extensor surface involvement in pediatric cases. Minor criteria, from erythema to elevated serum IgE (allergen-specific immunoglobulin E) levels, further contribute to a comprehensive diagnosis.

The hosts stress the importance of considering the evolving nature of AD, often lacking abrupt onset and manifesting as a persistent condition. This program offers valuable insights into optimizing care, with a focus on approved agents, clinical trial data, and the crucial role of advanced practice providers in tailoring treatment for individuals with AD.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.

Related Videos
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
© 2024 MJH Life Sciences

All rights reserved.